Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer ; volume:42 ; number:1 ; day:28 ; month:8 ; year:2023 ; pages:1 ; date:12.2023
Journal of experimental & clinical cancer research ; 42, Heft 1 (28.8.2023), 1, 12.2023

Creator: Heer, E. C. de
Zois, C. E.
Bridges, E.
Vegt, B. van der
Sheldon, H.
Veldman, W. A.
Zwager, M. C.
Sluis, T. van der
Haider, S.
Morita, T.
Baba, O.
Schröder, C. P.
Jong, S. de
Harris, A. L.
Jalving, M.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13046-023-02800-3

URN: urn:nbn:de:101:1-2023110711014329809236

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Heer, E. C. de
Zois, C. E.
Bridges, E.
Vegt, B. van der
Sheldon, H.
Veldman, W. A.
Zwager, M. C.
Sluis, T. van der
Haider, S.
Morita, T.
Baba, O.
Schröder, C. P.
Jong, S. de
Harris, A. L.
Jalving, M.
SpringerLink (Online service)

Other Objects (12)

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Metastatic Triple-Negative Breast Cancer

BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways

Characterizing triple-negative breast cancer tumors

Triple-Negative Breast Cancer: Multimodality Appearance

Mechanism of glycogen synthase inactivation and interaction with glycogenin

Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer

Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer

A novel mutation in the glycogen synthase 2 gene in a child with glycogen storage disease type 0

Hochschulschrift

Proteinexpression adulter neuronaler Stammzellen bei Inhibition der Glycogen-Synthase-Kinase-3

Hochschulschrift

MicroRNA signatures in triple-negative breast cancer

New Vaccine Therapy for Triple-Negative Breast Cancer

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Metastatic Triple-Negative Breast Cancer

BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways

Characterizing triple-negative breast cancer tumors

Triple-Negative Breast Cancer: Multimodality Appearance

Mechanism of glycogen synthase inactivation and interaction with glycogenin

Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer

Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer

A novel mutation in the glycogen synthase 2 gene in a child with glycogen storage disease type 0

Hochschulschrift

Proteinexpression adulter neuronaler Stammzellen bei Inhibition der Glycogen-Synthase-Kinase-3

Hochschulschrift

MicroRNA signatures in triple-negative breast cancer

New Vaccine Therapy for Triple-Negative Breast Cancer

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Metastatic Triple-Negative Breast Cancer

BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways

Characterizing triple-negative breast cancer tumors

Triple-Negative Breast Cancer: Multimodality Appearance

Mechanism of glycogen synthase inactivation and interaction with glycogenin

Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer

Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer

A novel mutation in the glycogen synthase 2 gene in a child with glycogen storage disease type 0

Hochschulschrift

Proteinexpression adulter neuronaler Stammzellen bei Inhibition der Glycogen-Synthase-Kinase-3

Hochschulschrift

MicroRNA signatures in triple-negative breast cancer

New Vaccine Therapy for Triple-Negative Breast Cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Metastatic Triple-Negative Breast Cancer

BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways

Characterizing triple-negative breast cancer tumors

Triple-Negative Breast Cancer: Multimodality Appearance

Mechanism of glycogen synthase inactivation and interaction with glycogenin

Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer

Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer

A novel mutation in the glycogen synthase 2 gene in a child with glycogen storage disease type 0

Proteinexpression adulter neuronaler Stammzellen bei Inhibition der Glycogen-Synthase-Kinase-3

MicroRNA signatures in triple-negative breast cancer

New Vaccine Therapy for Triple-Negative Breast Cancer

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Metastatic Triple-Negative Breast Cancer

BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways

Characterizing triple-negative breast cancer tumors

Triple-Negative Breast Cancer: Multimodality Appearance

Mechanism of glycogen synthase inactivation and interaction with glycogenin

Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer

Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer

A novel mutation in the glycogen synthase 2 gene in a child with glycogen storage disease type 0

Proteinexpression adulter neuronaler Stammzellen bei Inhibition der Glycogen-Synthase-Kinase-3

MicroRNA signatures in triple-negative breast cancer

New Vaccine Therapy for Triple-Negative Breast Cancer

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Metastatic Triple-Negative Breast Cancer

BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways

Characterizing triple-negative breast cancer tumors

Triple-Negative Breast Cancer: Multimodality Appearance

Mechanism of glycogen synthase inactivation and interaction with glycogenin

Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer

Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer

A novel mutation in the glycogen synthase 2 gene in a child with glycogen storage disease type 0

Proteinexpression adulter neuronaler Stammzellen bei Inhibition der Glycogen-Synthase-Kinase-3

MicroRNA signatures in triple-negative breast cancer

New Vaccine Therapy for Triple-Negative Breast Cancer

Related objects

Reset password